{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:24:01Z","timestamp":1786994641095,"version":"build-2736575974"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T00:00:00Z","timestamp":1733270400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Non-coding RNA Research"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ncrna.2024.12.002","type":"journal-article","created":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T02:49:19Z","timestamp":1734144559000},"page":"150-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Targeting microRNA methylation: Innovative approaches to diagnosing and treating hepatocellular carcinoma"],"prefix":"10.1016","volume":"11","author":[{"given":"Albert","family":"Sufianov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murad","family":"Agaverdiev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey","family":"Mashkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Ilyasova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ncrna.2024.12.002_bib1","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/apt.14913","article-title":"Review article: systemic treatment of hepatocellular carcinoma","volume":"48","author":"Pinter","year":"2018","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.ncrna.2024.12.002_bib2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ijc.32723","article-title":"International trends in hepatocellular carcinoma incidence, 1978-2012","volume":"147","author":"Petrick","year":"2020","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.ncrna.2024.12.002_bib3","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1093\/bib\/bbaa023","article-title":"The mechanistic, diagnostic and therapeutic novel nucleic acids for hepatocellular carcinoma emerging in past score years","volume":"22","author":"Zhang","year":"2021","journal-title":"Briefings Bioinf."},{"issue":"3","key":"10.1016\/j.ncrna.2024.12.002_bib4","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10238-020-00627-2","article-title":"The current state of MiRNAs as biomarkers and therapeutic tools","volume":"20","author":"Gareev","year":"2020","journal-title":"Clin. Exp. Med."},{"issue":"28","key":"10.1016\/j.ncrna.2024.12.002_bib5","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.2174\/1568026619666181224095449","article-title":"Epigenetic targets and their inhibitors in cancer therapy","volume":"18","author":"Zhao","year":"2018","journal-title":"Curr. Top. Med. Chem."},{"issue":"11","key":"10.1016\/j.ncrna.2024.12.002_bib6","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1021\/acs.analchem.3c05474","article-title":"Bringing to light the importance of the miRNA methylome in colorectal cancer prognosis through electrochemical bioplatforms","volume":"96","author":"Povedano","year":"2024","journal-title":"Anal. Chem."},{"issue":"2","key":"10.1016\/j.ncrna.2024.12.002_bib7","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/cbic.201402449","article-title":"miRNA and methylation: a multifaceted liaison","volume":"16","author":"Chhabra","year":"2015","journal-title":"Chembiochem"},{"issue":"19","key":"10.1016\/j.ncrna.2024.12.002_bib8","doi-asserted-by":"crossref","first-page":"7287","DOI":"10.3390\/ijms21197287","article-title":"MiRNAs as noninvasive biomarkers and therapeutic agents of pituitary adenomas","volume":"21","author":"Beylerli","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.ncrna.2024.12.002_bib9","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.3390\/genes14101856","article-title":"Decoding cancer evolution: integrating genetic and non-genetic insights","volume":"14","author":"Ashouri","year":"2023","journal-title":"Genes"},{"issue":"1","key":"10.1016\/j.ncrna.2024.12.002_bib10","doi-asserted-by":"crossref","first-page":"120","DOI":"10.37349\/etat.2024.00209","article-title":"The oncogenic role of hepatitis B virus X gene in hepatocarcinogenesis: recent updates","volume":"5","author":"Agustiningsih","year":"2024","journal-title":"Explor Target Antitumor Ther."},{"issue":"23","key":"10.1016\/j.ncrna.2024.12.002_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242317122","article-title":"miRNAs and substances abuse: clinical and forensic pathological implications: a systematic review","volume":"24","author":"Occhipinti","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"24","key":"10.1016\/j.ncrna.2024.12.002_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242417224","article-title":"Hepatitis B virus and microRNAs: a bioinformatics approach","volume":"24","author":"Zulian","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.ncrna.2024.12.002_bib13","first-page":"53","article-title":"MiR-205 dysregulations in breast cancer: the complexity and opportunities","volume":"5","author":"Xiao","year":"2019","journal-title":"Noncoding RNA"},{"key":"10.1016\/j.ncrna.2024.12.002_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101613","article-title":"MicroRNAs as clinical tools for diagnosis, prognosis, and therapy in prostate cancer","volume":"28","author":"Ghamlouche","year":"2023","journal-title":"Transl Oncol"},{"issue":"9","key":"10.1016\/j.ncrna.2024.12.002_bib15","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.3390\/cells9091957","article-title":"miR-205: a potential biomedicine for cancer therapy","volume":"9","author":"Chauhan","year":"2020","journal-title":"Cells"},{"issue":"31","key":"10.1016\/j.ncrna.2024.12.002_bib16","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.3748\/wjg.v29.i31.4706","article-title":"Dysregulated microRNAs as a biomarker for diagnosis and prognosis of hepatitis B virus-associated hepatocellular carcinoma","volume":"29","author":"Zhang","year":"2023","journal-title":"World J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.ncrna.2024.12.002_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2020.152981","article-title":"Hepatitis B virus X protein boosts hepatocellular carcinoma progression by downregulating microRNA-137","volume":"216","author":"Gao","year":"2020","journal-title":"Pathol. Res. Pract."},{"issue":"3","key":"10.1016\/j.ncrna.2024.12.002_bib18","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.3390\/ijms24032805","article-title":"The roles of epigenetic regulation and the tumor microenvironment in the mechanism of resistance to systemic therapy in hepatocellular carcinoma","volume":"24","author":"Oura","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.ncrna.2024.12.002_bib19","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.acthis.2017.12.004","article-title":"MiR-199-3p replacement affects E-cadherin expression through Notch1 targeting in hepatocellular carcinoma","volume":"120","author":"Giovannini","year":"2018","journal-title":"Acta Histochem."},{"issue":"7","key":"10.1016\/j.ncrna.2024.12.002_bib20","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00104-022-01661-4","article-title":"Hepatozellul\u00e4res karzinom [hepatocellular carcinoma]","volume":"93","author":"Braun","year":"2022","journal-title":"Chirurgie (Heidelb)"},{"issue":"3","key":"10.1016\/j.ncrna.2024.12.002_bib21","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3390\/molecules21030370","article-title":"Production of fusaric acid by Fusarium spp. in pure culture and in solid medium Co-cultures","volume":"21","author":"Bohni","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.ncrna.2024.12.002_bib22","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.3389\/fphar.2018.01443","article-title":"Immunomodulatory properties of DNA hypomethylating agents: selecting the optimal epigenetic partner for cancer immunotherapy","volume":"9","author":"Fazio","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"8","key":"10.1016\/j.ncrna.2024.12.002_bib23","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1080\/15592294.2019.1615358","article-title":"Fusaric acid-induced promoter methylation of DNA methyltransferases triggers DNA hypomethylation in human hepatocellular carcinoma (HepG2) cells","volume":"14","author":"Ghazi","year":"2019","journal-title":"Epigenetics"},{"issue":"1","key":"10.1016\/j.ncrna.2024.12.002_bib24","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13045-018-0555-y","article-title":"miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a","volume":"11","author":"Cao","year":"2018","journal-title":"J. Hematol. Oncol."},{"issue":"11","key":"10.1016\/j.ncrna.2024.12.002_bib25","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1158\/1541-7786.MCR-17-0762","article-title":"Elevated miR-182-5p associates with renal cancer cell mitotic arrest through diminished MALAT-1 expression","volume":"16","author":"Kulkarni","year":"2018","journal-title":"Mol. Cancer Res."},{"issue":"19","key":"10.1016\/j.ncrna.2024.12.002_bib26","doi-asserted-by":"crossref","first-page":"7287","DOI":"10.3390\/ijms21197287","article-title":"MiRNAs as noninvasive biomarkers and therapeutic agents of pituitary adenomas","volume":"21","author":"Beylerli","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ncrna.2024.12.002_bib27","first-page":"208","article-title":"The role of miR-182-5p in hepatocarcinogenesis of trichloroethylene in mice","volume":"156","author":"Jiang","year":"2017","journal-title":"Toxicol. Sci."},{"issue":"4","key":"10.1016\/j.ncrna.2024.12.002_bib28","doi-asserted-by":"crossref","first-page":"310","DOI":"10.5271\/sjweh.1078","article-title":"Dry cleaning, some solvents used in dry cleaning and other industrial chemicals. IARC meeting, Lyon, 7-14 February 1995","volume":"21","author":"McGregor","year":"1995","journal-title":"Scand. J. Work. Environ. Health"},{"key":"10.1016\/j.ncrna.2024.12.002_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101581","article-title":"MicroRNAs in non-alcoholic fatty liver disease: progress and perspectives","volume":"65","author":"Hochreuter","year":"2022","journal-title":"Mol. Metabol."},{"issue":"Pt A","key":"10.1016\/j.ncrna.2024.12.002_bib30","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.fct.2016.06.027","article-title":"Irreversible down-regulation of miR-375 in the livers of Fischer 344 rats after chronic furan exposure","volume":"98","author":"de Conti","year":"2016","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ncrna.2024.12.002_bib31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ab.2018.02.012","article-title":"Label-free electrochemical aptasensor for detection of alpha-fetoprotein based on AFP-aptamer and thionin\/reduced graphene oxide\/gold nanoparticles","volume":"547","author":"Li","year":"2018","journal-title":"Anal. Biochem."},{"issue":"1","key":"10.1016\/j.ncrna.2024.12.002_bib32","first-page":"43","article-title":"Evaluation of serum \u03b1-fetoprotein levels during different infection phases of CHB patients","volume":"64","author":"Yang","year":"2018","journal-title":"Clin. Lab."},{"issue":"2","key":"10.1016\/j.ncrna.2024.12.002_bib33","doi-asserted-by":"crossref","first-page":"536","DOI":"10.7150\/ijbs.64537","article-title":"The landscape of alpha fetoprotein in hepatocellular carcinoma: where are we?","volume":"18","author":"Hu","year":"2022","journal-title":"Int. J. Biol. Sci."},{"issue":"12","key":"10.1016\/j.ncrna.2024.12.002_bib34","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.4254\/wjh.v14.i12.1985","article-title":"Role of microRNA-regulated cancer stem cells in recurrent hepatocellular carcinoma","volume":"14","author":"Li","year":"2022","journal-title":"World J. Hepatol."},{"issue":"5","key":"10.1016\/j.ncrna.2024.12.002_bib35","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/ncb1722","article-title":"The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1","volume":"10","author":"Gregory","year":"2008","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ncrna.2024.12.002_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2019.144025","article-title":"Integrative data mining and meta-analysis to investigate the prognostic role of microRNA-200 family in various human malignant neoplasms: a consideration on heterogeneity","volume":"716","author":"Yuan","year":"2019","journal-title":"Gene"},{"issue":"14","key":"10.1016\/j.ncrna.2024.12.002_bib37","doi-asserted-by":"crossref","first-page":"18684","DOI":"10.18632\/oncotarget.7629","article-title":"Methylation-associated silencing of miR-200b facilitates human hepatocellular carcinoma progression by directly targeting BMI1","volume":"7","author":"Wu","year":"2016","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.ncrna.2024.12.002_bib38","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1002\/mc.22657","article-title":"The miR-200b-ZEB1 circuit regulates diverse stemness of human hepatocellular carcinoma","volume":"56","author":"Tsai","year":"2017","journal-title":"Mol. Carcinog."},{"issue":"20","key":"10.1016\/j.ncrna.2024.12.002_bib39","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.1158\/0008-5472.CAN-19-0255","article-title":"Roles and regulation of long noncoding RNAs in hepatocellular carcinoma","volume":"79","author":"Lim","year":"2019","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.ncrna.2024.12.002_bib40","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1158\/0008-5472.CAN-18-1675","article-title":"miR-192-5p silencing by genetic aberrations is a key event in hepatocellular carcinomas with cancer stem cell features","volume":"79","author":"Gu","year":"2019","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.ncrna.2024.12.002_bib41","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12384","article-title":"Loss-of-function of miR-142 by hypermethylation promotes TGF-\u03b2-mediated tumour growth and metastasis in hepatocellular carcinoma","volume":"50","author":"Yu","year":"2017","journal-title":"Cell Prolif."},{"issue":"14","key":"10.1016\/j.ncrna.2024.12.002_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411544","article-title":"Gender differences and miRNAs expression in cancer: implications on prognosis and susceptibility","volume":"24","author":"Caserta","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"39","key":"10.1016\/j.ncrna.2024.12.002_bib43","doi-asserted-by":"crossref","first-page":"42040","DOI":"10.18632\/oncotarget.5969","article-title":"Comprehensive profiling of novel microRNA-9 targets and a tumor suppressor role of microRNA-9 via targeting IGF2BP1 in hepatocellular carcinoma","volume":"6","author":"Zhang","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.ncrna.2024.12.002_bib44","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3390\/ijms25010597","article-title":"HCC-related lncRNAs: roles and mechanisms","volume":"25","author":"Shah","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"18","key":"10.1016\/j.ncrna.2024.12.002_bib45","doi-asserted-by":"crossref","first-page":"26027","DOI":"10.18632\/oncotarget.8266","article-title":"Methylation-regulated miR-124-1 suppresses tumorigenesis in hepatocellular carcinoma by targeting CASC3","volume":"7","author":"Xu","year":"2016","journal-title":"Oncotarget"},{"issue":"24","key":"10.1016\/j.ncrna.2024.12.002_bib46","doi-asserted-by":"crossref","first-page":"36909","DOI":"10.18632\/oncotarget.9377","article-title":"Methylation-mediated repression of microRNA-129-2 suppresses cell aggressiveness by inhibiting high mobility group box 1 in human hepatocellular carcinoma","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ncrna.2024.12.002_bib47","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1476-4598-14-5","article-title":"microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma","volume":"14","author":"Zhang","year":"2015","journal-title":"Mol. Cancer"},{"issue":"5","key":"10.1016\/j.ncrna.2024.12.002_bib48","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1478-3231.2012.02795.x","article-title":"MicroRNA profiling of hepatocarcinogenesis identifies C19MC cluster as a novel prognostic biomarker in hepatocellular carcinoma","volume":"32","author":"Augello","year":"2012","journal-title":"Liver Int."},{"issue":"3","key":"10.1016\/j.ncrna.2024.12.002_bib49","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/path.3995","article-title":"In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A\/p21, PTEN, AKT3 and TIMP2","volume":"227","author":"Fornari","year":"2012","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.ncrna.2024.12.002_bib50","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s12964-024-01595-w","article-title":"Clinical significance of RNA methylation in hepatocellular carcinoma","volume":"22","author":"Bao","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.ncrna.2024.12.002_bib51","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.omto.2020.05.011","article-title":"Hypomethylation causes MIR21 overexpression in tumors","volume":"18","author":"Lu","year":"2020","journal-title":"Mol Ther Oncolytics"},{"issue":"1","key":"10.1016\/j.ncrna.2024.12.002_bib52","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.canlet.2015.04.023","article-title":"MiR-429 increases the metastatic capability of HCC via regulating classic Wnt pathway rather than epithelial-mesenchymal transition","volume":"364","author":"Tang","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ncrna.2024.12.002_bib53","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/1609575","article-title":"New insights into the epigenetics of hepatocellular carcinoma","volume":"2017","author":"Wahid","year":"2017","journal-title":"BioMed Res. Int."},{"issue":"3","key":"10.1016\/j.ncrna.2024.12.002_bib54","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.3390\/molecules28031356","article-title":"Targeting Nrf2 and NF-\u03baB signaling pathways in cancer prevention: the role of apple phytochemicals","volume":"28","author":"Gado","year":"2023","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.ncrna.2024.12.002_bib55","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1007\/s10143-020-01427-8","article-title":"Diagnostic and prognostic potential of circulating miRNAs for intracranial aneurysms","volume":"44","author":"Gareev","year":"2021","journal-title":"Neurosurg. Rev."},{"issue":"S3","key":"10.1016\/j.ncrna.2024.12.002_bib56","doi-asserted-by":"crossref","first-page":"219","DOI":"10.7314\/APJCP.2016.17.S3.219","article-title":"Evaluation of MiR-34 family and DNA methyltransferases 1, 3A, 3B gene expression levels in hepatocellular carcinoma following treatment with dendrosomal nanocurcumin","volume":"17","author":"Chamani","year":"2016","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"issue":"10","key":"10.1016\/j.ncrna.2024.12.002_bib57","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.phymed.2015.05.071","article-title":"Dendrosomal curcumin increases expression of the long non-coding RNA gene MEG3 via up-regulation of epi-miRs in hepatocellular cancer","volume":"22","author":"Zamani","year":"2015","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ncrna.2024.12.002_bib58","article-title":"Circulating miRNAs as diagnostic and prognostic biomarkers in high-grade gliomas","volume":"12","author":"Wu","year":"2022","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.ncrna.2024.12.002_bib59","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.2174\/1570159X20666220507021445","article-title":"The role of mitochondria-targeting miRNAs in intracerebral hemorrhage","volume":"21","author":"Gareev","year":"2023","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ncrna.2024.12.002_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1157558","article-title":"Casticin as potential anticancer agent: recent advancements in multi-mechanistic approaches","volume":"10","author":"Carbone","year":"2023","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ncrna.2024.12.002_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.172982","article-title":"Long non-coding RNA ROR confers arsenic trioxide resistance to HepG2 cells by inhibiting p53 expression","volume":"872","author":"Li","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"47","key":"10.1016\/j.ncrna.2024.12.002_bib62","doi-asserted-by":"crossref","first-page":"7249","DOI":"10.1038\/s41388-019-0930-3","article-title":"Synergy between arsenic trioxide and JQ1 on autophagy in pancreatic cancer","volume":"38","author":"Xu","year":"2019","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.ncrna.2024.12.002_bib63","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1186\/s13063-018-2812-3","article-title":"Arsenic trioxide and all-trans retinoic acid (ATRA) treatment for acute promyelocytic leukemia in all risk groups: study protocol for a randomized controlled trial","volume":"19","author":"Zhang","year":"2018","journal-title":"Trials"},{"issue":"2","key":"10.1016\/j.ncrna.2024.12.002_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2019.111739","article-title":"De-methylation of miR-148a by arsenic trioxide enhances sensitivity to chemotherapy via inhibiting the NF-\u03baB pathway and CSC like properties","volume":"386","author":"Wang","year":"2020","journal-title":"Exp. Cell Res."},{"issue":"8","key":"10.1016\/j.ncrna.2024.12.002_bib65","doi-asserted-by":"crossref","first-page":"5639","DOI":"10.1074\/jbc.M111.291229","article-title":"DNA methylation-regulated miR-193a-3p dictates resistance of hepatocellular carcinoma to 5-fluorouracil via repression of SRSF2 expression","volume":"287","author":"Ma","year":"2012","journal-title":"J. Biol. Chem."}],"container-title":["Non-coding RNA Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468054024001665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468054024001665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T18:53:55Z","timestamp":1762628035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468054024001665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":65,"alternative-id":["S2468054024001665"],"URL":"https:\/\/doi.org\/10.1016\/j.ncrna.2024.12.002","relation":{},"ISSN":["2468-0540"],"issn-type":[{"value":"2468-0540","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting microRNA methylation: Innovative approaches to diagnosing and treating hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Non-coding RNA Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncrna.2024.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":". 2024 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}